This market research study presents a detailed segmentation of the global women’s health market by application (post-menopausal osteoporosis, infertility, endometriosis, contraceptives, menopause, and polycystic ovary syndrome) and by geography (Americas, APAC, Europe, and MEA). The key vendors in the market are Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals.
Technavio’s market research analysts estimate the global women’s health market, to grow at a CAGR of around 3% between 2016 and 2020. One of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries. However, the women’s health market is expected to witness increased availability and ease of purchase of women’s health solutions in many parts of the world by 2020. Moreover, governments and NGOs are taking up various awareness programs about the risks of different diseases. The Americas lead the women’s health market globally accounting for 40% of the overall market share. Much of this region’s growth comes from the rising number of older women affected by diseases such as breast cancer, endometriosis, and postmenopausal osteoporosis.
The new market research report from Technavio provides a breakdown and analysis of the women’s health segments by technology.
“Growing awareness of birth control methods is expected to propel the growth of this market in the forecast period. Contraception and fertility control are supported by the governments of developing nations such as India and China to curb the growing population. However, in western countries women have stopped using contraceptive pill due to their side effects and are increasingly using IUDs and implants. Therefore, the increasing awareness about alternative growth methods will aid in the growth of this market until the end of 2020,” says Amber Chourasia, Lead Analyst, Lab Automation and Health and Wellness, Technavio Research
Currently, the postmenopausal osteoporosis segment dominates the market, accounting for more than 37% of the market share. Factors such as the rising number of older people worldwide. Women above 50 are likely to be affected with postmenopausal symptoms due to various hormonal changes. According to the International Osteoporosis Foundation, it is estimated that close to 200 million women will be affected by postmenopausal osteoporosis globally, thereby spurring the growth of this market segment over the forecast period.
Global postmenopausal osteoporosis market 2015-2020 ($ billions)
Source: Technavio, 2016
The leading vendors in the global women’s health market include Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals. The market is highly fragmented and is characterized by the presence of several international and regional vendors. The vendors in this market compete in terms of price, quality, product differentiation, distribution, and promotion to gain maximum market prominence during the forecast period. The competitive environment is likely to intensify with an increase in product or service extensions, product innovations, and M&A.
A more detailed analysis is available in the Technavio report, Global Women’s Health Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
